401
Views
68
CrossRef citations to date
0
Altmetric
Review Article

Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study

, , , , &
Pages 12-41 | Received 08 Jun 2018, Accepted 28 Aug 2018, Published online: 11 Feb 2019

References

  • Agarwal S, Zhou X, Ye F, He Q, Chen GC, Soo J, Boey F, Zhang H, Chen P. 2010. Interfacing live cells with nanocarbon substrates. Langmuir. 26:2244–2247.
  • Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Luebbe AS. 2000. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60:6641–6648.
  • Almeida JPM, Chen AL, Foster A, Drezek R. 2011. In vivo biodistribution of nanoparticles. Nanomedicine. 6:815–835.
  • Bao H, Pan Y, Li L. 2012. Recent advances in graphene-based nanomaterials for biomedical applications. Nano Life. 2:1230001.
  • Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, Li J, Gan LH. 2011. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 7:1569–1578.
  • Barahuie F, Saifullah B, Dorniani D, Fakurazi S, Karthivashan G, Hussein MZ, Elfghi FM. 2017. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid. Mater Sci Eng: C. 74:177–185.
  • Becerril HA, Mao J, Liu Z, Stoltenberg RM, Bao Z, Chen Y. 2008. Evaluation of solution-processed reduced graphene oxide films as transparent conductors. ACS Nano. 2:463–470.
  • Bielawski C, Dreyer D, Park S, Ruoff R. 2010. The chemistry of graphene oxide. Chem Soc Rev. 39:228–240.
  • Buffa F, Hu H, Resasco DE. 2005. Side-wall functionalization of single-walled carbon nanotubes with 4-hydroxymethylaniline followed by polymerization of ε-caprolactone. Macromolecules. 38:8258–8263.
  • Burke TG, Mi Z. 1994. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J Med Chem. 37:40–46.
  • Chang Y, Yang S-T, Liu J-H, Dong E, Wang Y, Cao A, Liu Y, Wang H. 2011. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett. 200:201–210.
  • Chen B, Liu M, Zhang L, Huang J, Yao J, Zhang Z. 2011a. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J Mater Chem. 21:7736.
  • Chen G-Y, Meng C-L, Lin K-C, Tuan H-Y, Yang H-J, Chen C-L, Li K-C, Chiang C-S, Hu Y-C. 2015. Graphene oxide as a chemosensitizer: diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects. Biomaterials. 40:12–22.
  • Chen G-Y, Pang D-P, Hwang S-M, Tuan H-Y, Hu Y-C. 2012. A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials. 33:418–427.
  • Chen H, Wang Z, Zong S, Wu L, Chen P, Zhu D, Wang C, Xu S, Cui Y. 2014. SERS-fluorescence monitored drug release of a redox-responsive nanocarrier based on graphene oxide in tumor cells. ACS Appl Mater Interfaces. 6:17526–17533.
  • Chen S, Hai X, Xia C, Chen XW, Wang JH. 2013. Preparation of excitation‐independent photoluminescent graphene quantum dots with visible‐light excitation/emission for cell imaging. Chem Eur J.19:15918–15923.
  • Chen W, Yi P, Zhang Y, Zhang L, Deng Z, Zhang Z. 2011b. Composites of aminodextran-coated fe3o4 nanoparticles and graphene oxide for cellular magnetic resonance imaging. ACS Appl Mater Interfaces. 3:4085–4091.
  • Chen Y, Chen H, Shi J. 2014. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells. Mol Pharmaceutics. 11:2495–2510.
  • Chen Y, Xu P, Shu Z, Wu M, Wang L, Zhang S, Zheng Y, Chen H, Wang J, Li Y, Shi J. 2014. Multifunctional graphene oxide‐based triple stimuli‐responsive nanotheranostics. Adv Funct Mater. 24:4386–4396.
  • Cheng L, Yang K, Li Y, Chen J, Wang C, Shao M, Lee ST, Liu Z. 2011. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual‐targeted photothermal therapy. Angew Chem. 123:7523–7528.
  • Cheng L, Yang K, Li Y, Zeng X, Shao M, Lee S-T, Liu Z. 2012. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials. 33:2215–2222.
  • Cheng L, Yang K, Shao M, Lu X, Liu Z. 2011. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine. 6:1327–1340.
  • Chertok B, David AE, Yang VC. 2010. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials. 31:6317–6324.
  • Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. 2008. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 29:487–496.
  • Cohen-Karni T, Qing Q, Li Q, Fang Y, Lieber CM. 2010. Graphene and nanowire transistors for cellular interfaces and electrical recording. Nano Lett. 10:1098–1102.
  • Davis ME, Chen Z, Shin DM. 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 7:771–782.
  • Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases. In: Inflammatory pocesses. Birkhäuser, Basel: Springer; p. 13–21.
  • Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases in inflammatory processes. Springer; p. 13–21.
  • Dembereldorj U, Kim M, Kim S, Ganbold E-O, Lee SY, Joo S-W. 2012. A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo. J Mater Chem. 22:23845–23851.
  • Depan D, Girase B, Shah J, Misra R. 2011. Structure–process–property relationship of the polar graphene oxide-mediated cellular response and stimulated growth of osteoblasts on hybrid chitosan network structure nanocomposite scaffolds. Acta Biomater. 7:3432–3445.
  • Depan D, Shah J, Misra R. 2011. Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mater Sci Eng: C. 31:1305–1312.
  • Dong H, Gao W, Yan F, Ji H, Ju H. 2010. Fluorescence resonance energy transfer between quantum dots and graphene oxide for sensing biomolecules. Anal Chem. 82:5511–5517.
  • Dong L, Joseph KL, Witkowski CM, Craig MM. 2008. Cytotoxicity of single-walled carbon nanotubes suspended in various surfactants. Nanotechnology. 19:255702.
  • Duch MC, Budinger GRS, Liang YT, Soberanes S, Urich D, Chiarella SE, Campochiaro LA, Gonzalez A, Chandel NS, Hersam MC, Mutlu GM. 2011. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 11:5201–5207.
  • Fan H, Wang L, Zhao K, Li N, Shi Z, Ge Z, Jin Z. 2010. Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules. 11:2345–2351.
  • Fan X, Jiao G, Gao L, Jin P, Li X. 2013. The preparation and drug delivery of a graphene–carbon nanotube–Fe3O4 nanoparticle hybrid. J Mater Chem B. 1:2658–2664.
  • Fang J, Nakamura H, Maeda H. 2011. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 63:136–151.
  • Feng L, Liu Z. 2011. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 6:317–324.
  • Feng L, Wu L, Qu X. 2013. New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv Mater Weinheim. 25:168–186.
  • Feng L, Zhang S, Liu Z. 2011. Graphene based gene transfection. Nanoscale. 3:1252–1257.
  • Gao J, Bao F, Feng L, Shen K, Zhu Q, Wang D, Chen T, Ma R, Yan C. 2011. Functionalized graphene oxide modified polysebacic anhydride as drug carrier for levofloxacin controlled release. RSC Adv. 1:1737.
  • Geim AK, Novoselov KS. 2007. The rise of graphene. Nat Mater. 6:183.
  • Geim AK. 2009. Graphene: status and prospects. Science. 324:1530–1534.
  • Ghosh D, Chandra S, Chakraborty A, Ghosh SK, Pramanik P. 2010. A novel graphene oxide-para amino benzoic acid nanosheet as effective drug delivery system to treat drug resistant bacteria. Int J Pharm Sci Drug Res. 2:127–133.
  • Goenka S, Sant V, Sant S. 2014. Graphene-based nanomaterials for drug delivery and tissue engineering. J Control Release. 173:75–88.
  • Gonçalves G, Vila M, Portolés M-T, Vallet-Regi M, Gracio J, Marques PAAP. 2013. Nano-graphene oxide: a potential multifunctional platform for cancer therapy. Adv Healthcare Mater. 2:1072–1090.
  • Guo M, Yan Y, Zhang H, Yan H, Cao Y, Liu K, Wan S, Huang J, Yue W. 2008. Magnetic and pH-responsive nanocarriers with multilayer core–shell architecture for anticancer drug delivery. J Mater Chem. 18:5104.
  • Haynesworth S, Goshima J, Goldberg V, Caplan A. 1992. Characterization of cells with osteogenic potential from human marrow. Bone. 13:81–88.
  • He Q, Sudibya HG, Yin Z, Wu S, Li H, Boey F, Huang W, Chen P, Zhang H. 2010. Centimeter-long and large-scale micropatterns of reduced graphene oxide films: fabrication and sensing applications. ACS Nano. 4:3201–3208.
  • Hu H, Yu J, Li Y, Zhao J, Dong H. 2012. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res. 100A:141–148.
  • Hu W, Peng C, Luo W, Lv M, Li X, Li D, Huang Q, Fan C. 2010. Graphene-based antibacterial paper. ACS Nano. 4:4317–4323.
  • Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, Zhou X, Guo S, Cui D. 2011. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics. 1:240.
  • Kakran M, G Sahoo N, Bao H, Pan Y, Li L. 2011. Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic acid. CMC. 18:4503–4512.
  • Kanakia S, Toussaint JD, Chowdhury SM, Tembulkar T, Lee S, Jiang Y-P, Lin RZ, Shroyer KR, Moore W, Sitharaman B. 2014. Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials. 35:7022–7031.
  • Kasry A, Afzali AA, Oida S, Han S-J, Menges B, Tulevski GS. 2011. Detection of biomolecules via benign surface modification of graphene. Chem Mater. 23:4879–4881.
  • Kawakami K, Ebara M, Izawa HM, Sanchez-Ballester NP, Hill J, Ariga K. 2012. Supramolecular approaches for drug development. Curr Med Chem. 19:2388–2398.
  • Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, Minko T. 2006. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjugate Chem. 17:1464–1472.
  • Kim CS, Duncan B, Creran B, Rotello VM. 2013. Triggered nanoparticles as therapeutics. Nano Today. 8:439–447.
  • Kim H, Kim WJ. 2014. Photothermally controlled gene delivery by reduced graphene oxide–polyethylenimine nanocomposite. Small. 10:117–126.
  • Kim H, Lee D, Kim J, Kim T-i, Kim WJ. 2013. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano. 7:6735–6746.
  • Kim H, Namgung R, Singha K, Oh I-K, Kim WJ. 2011. Graphene oxide–polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjugate Chem. 22:2558–2567.
  • Kodali VK, Scrimgeour J, Kim S, Hankinson JH, Carroll KM, De Heer WA, Berger C, Curtis JE. 2011. Nonperturbative chemical modification of graphene for protein micropatterning. Langmuir. 27:863–865.
  • Ku SH, Park CB. 2013. Myoblast differentiation on graphene oxide. Biomaterials. 34:2017–2023.
  • Kuila T, Bose S, Mishra AK, Khanra P, Kim NH, Lee JH. 2012. Chemical functionalization of graphene and its applications. Progr Mater Sci. 57:1061–1105.
  • La W-G, Park S, Yoon H-H, Jeong G-J, Lee T-J, Bhang SH, Han JY, Char K, Kim B-S. 2013. Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. Small. 9:4051–4060.
  • Langer R. 2001. Drug delivery: drugs on Target. Science. 293:58–59.
  • Lee DY, Khatun Z, Lee J-H, Lee Y-k, In I. 2011. Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules. 12:336–341.
  • Lee EJ, Lee JH, Shin YC, Hwang D-G, Kim JS, Jin OS, Jin L, Hong SW, Han D-W. 2014. Graphene oxide-decorated PLGA/collagen hybrid fiber sheets for application to tissue engineering scaffolds. Biomater Res. 18:18–24.
  • Lee WC, Lim CHY, Shi H, Tang LA, Wang Y, Lim CT, Loh KP. 2011. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide. ACS Nano. 5:7334–7341.
  • Lei H, Mi L, Zhou X, Chen J, Hu J, Guo S, Zhang Y. 2011. Adsorption of double-stranded DNA to graphene oxide preventing enzymatic digestion. Nanoscale. 3:3888.
  • Li C, Adamcik J, Mezzenga R. 2012. Biodegradable nanocomposites of amyloid fibrils and graphene with shape-memory and enzyme-sensing properties. Nature Nanotech. 7:421–427.
  • Li N, Zhang Q, Gao S, Song Q, Huang R, Wang L, Liu L, Dai J, Tang M, Cheng G. 2013. Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells. Sci Rep. 3:1604.
  • Li Y, Liu Y, Fu Y, Wei TL, Guyader L, Gao G, Liu R-S, Chang Y-Z, Chen C. 2012. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials. 33:402–411.
  • Liao K-H, Lin Y-S, Macosko CW, Haynes CL. 2011. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces. 3:2607–2615.
  • Lim H, Huang N, Lim S, Harrison I, Chia CH. 2011. Fabrication and characterization of graphene hydrogel via hydrothermal approach as a scaffold for preliminary study of cell growth. Int J Nanomed. 6:1817.
  • Liu H-W, Hu S-H, Chen Y-W, Chen S-Y. 2012. Characterization and drug release behavior of highly responsive chip-like electrically modulated reduced graphene oxide–poly(vinyl alcohol) membranes. J Mater Chem. 22:17311.
  • Liu J, Cui L, Losic D. 2013. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 9:9243–9257.
  • Liu J-H, Yang S-T, Wang H, Chang Y, Cao A, Liu Y. 2012. Effect of size and dose on the biodistribution of graphene oxide in mice. Nanomedicine. 7:1801–1812.
  • Liu K, Zhang J-J, Cheng F-F, Zheng T-T, Wang C, Zhu J-J. 2011. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J Mater Chem. 21:12034–12040.
  • Liu Y, Yu D, Zeng C, Miao Z, Dai L. 2010. Biocompatible graphene oxide-based glucose biosensors. Langmuir. 26:6158–6160.
  • Liu Z, Robinson JT, Sun X, Dai H. 2008. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 130:10876–10877.
  • Liu Z, Robinson JT, Tabakman SM, Yang K, Dai H. 2011. Carbon materials for drug delivery & cancer therapy. Mater Today. 14:316–323.
  • Liu Z, Sun X, Nakayama-Ratchford N, Dai H. 2007. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 1:50–56.
  • Liu Z, Wang Y, Zhang N. 2012. Micelle-like nanoassemblies based on polymer–drug conjugates as an emerging platform for drug delivery. Expert Opin Drug Deliv. 9:805–822.
  • Loh KP, Bao Q, Eda G, Chhowalla M. 2010. Graphene oxide as a chemically tunable platform for optical applications. Nat Chem. 2:1015–1024.
  • Loutfy SA, Salaheldin TA, Ramadan MA, Farroh KY, Abdallah ZF, Youssef T. 2017. Synthesis, characterization and cytotoxic evaluation of graphene oxide nanosheets: in vitro liver cancer model. Asian Pac J Cancer Prev. 18:955.
  • Lu B, Li T, Zhao H, Li X, Gao C, Zhang S, Xie E. 2012. Graphene-based composite materials beneficial to wound healing. Nanoscale. 4:2978.
  • Lu CH, Yang HH, Zhu CL, Chen X, Chen GN. 2009. A graphene platform for sensing biomolecules. Angew Chem. 121:4879–4881.
  • Lu C-H, Zhu C-L, Li J, Liu J-J, Chen X, Yang H-H. 2010. Using graphene to protect DNA from cleavage during cellular delivery. Chem Commun. 46:3116.
  • Lv X, Huang Y, Liu Z, Tian J, Wang Y, Ma Y, Liang J, Fu S, Wan X, Chen Y. 2009. Photoconductivity of bulk-film-based graphene sheets. Small.5:1682–1687.
  • Ma X, Tao H, Yang K, Feng L, Cheng L, Shi X, Li Y, Guo L, Liu Z. 2012. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 5:199–212.
  • Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. 2011. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 63:24–46.
  • Mainardes R, Silva L. 2004. Drug delivery systems: past, present, and future. Curr Drug Targets. 5:449–455.
  • Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, Kepić DP, Arsikin KM, Jovanović SP, Pantovic AC, Dramićanin MD, Trajkovic VS. 2011. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials. 32:1121–1129.
  • Miao W, Shim G, Lee S, Lee S, Choe YS, Oh Y-K. 2013. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials. 34:3402–3410.
  • Mintzer MA, Simanek EE. 2009. Nonviral vectors for gene delivery. Chem Rev. 109:259–302.
  • Nayak TR, Andersen H, Makam VS, Khaw C, Bae S, Xu X, Ee P-LR, Ahn J-H, Hong BH, Pastorin G, Özyilmaz B. 2011. Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells. ACS Nano. 5:4670–4678.
  • Neto AC, Guinea F, Peres NM, Novoselov KS, Geim AK. 2009. The electronic properties of graphene. Rev Mod Phys. 81:109.
  • Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, Dubonos SV, Grigorieva IV, Firsov AA. 2004. Electric field effect in atomically thin carbon films. Science. 306:666–669.
  • O’Dwyer PJ, Stevenson JP, Johnson SW. 1999. Clinical status of cisplatin, carboplatin, and other platinum‐based antitumor drugs. In: Lippert B, editor. Cisplatin: Chemistry and biochemistry of a leading anticancer drug; Zürich, Switzerland: Verlag Helvetica Chimica Acta; p. 29–69.
  • Pahuja P, Arora S, Pawar P. 2012. Ocular drug delivery system: a reference to natural polymers. Expert Opin Drug Deliv. 9:837–861.
  • Pal MK, Jaiswar SP, Dwivedi A, Goyal S, Dwivedi VN, Pathak AK, Kumar V, Sankhwar PL, Ray RS. 2017. Synergistic effect of graphene oxide coated nanotised apigenin with paclitaxel (GO-NA/PTX): a ROS dependent mitochondrial mediated apoptosis in ovarian cancer. Anti-Cancer Agents Med Chem. 17:1721–1732.
  • Pan Y, Bao H, Sahoo NG, Wu T, Li L. 2011. Water‐soluble poly (N‐isopropylacrylamide)–graphene sheets synthesized via click chemistry for drug delivery. Adv Funct Mater. 21:2754–2763.
  • Pan Y, Sahoo NG, Li L. 2012. The application of graphene oxide in drug delivery. Expert Opin Drug Deliv. 9:1365–1376.
  • Pasricha R, Gupta S, Srivastava AK. 2009. A facile and novel synthesis of Ag-graphene-based nanocomposites. Small. 5:2253–2259.
  • Posati T, Bellezza F, Tarpani L, Perni S, Latterini L, Marsili V, Cipiciani A. 2012. Selective internalization of ZnAl-HTlc nanoparticles in normal and tumor cells. A study of their potential use in cellular delivery. Appl Clay Sci. 55:62–69.
  • Rana VK, Choi MC, Kong JY, Kim GY, Kim MJ, Kim SH, Mishra S, Singh RP, Ha CS. 2011. Synthesis and drug‐delivery behavior of chitosan‐functionalized graphene oxide hybrid nanosheets. Macromol Mater Eng. 296:131–140.
  • Rao C, Biswas K, Subrahmanyam K, Govindaraj A. 2009. Graphene, the new nanocarbon. J Mater Chem. 19:2457–2469.
  • Robinson JT, Tabakman SM, Liang Y, Wang H, Sanchez Casalongue H, Vinh D, Dai H. 2011. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 133:6825–6831.
  • Ryoo S-R, Kim Y-K, Kim M-H, Min D-H. 2010. Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano. 4:6587–6598.
  • Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, Cheng HKF, Li L, Tan LP. 2011. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem Commun. 47:5235.
  • Sahu A, Choi WI, Lee JH, Tae G. 2013. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials. 34:6239–6248.
  • Sant S, Hancock MJ, Donnelly JP, Iyer D, Khademhosseini A. 2010. Biomimetic gradient hydrogels for tissue engineering. Can J Chem Eng. 88:899–911.
  • Shan C, Yang H, Han D, Zhang Q, Ivaska A, Niu L. 2009. Water-soluble graphene covalently functionalized by biocompatible poly-l-lysine. Langmuir. 25:12030–12033.
  • Shen AJ, Li DL, Cai XJ, Dong CY, Dong HQ, Wen HY, Dai GH, Wang PJ, Li YY. 2012a. Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J Biomed Mater Res Part A. 100:2499–2506.
  • Shen H, Liu M, He H, Zhang L, Huang J, Chong Y, Dai J, Zhang Z. 2012b. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl Mater Interfaces. 4:6317–6323.
  • Shen H, Zhang L, Liu M, Zhang Z. 2012c. Biomedical applications of graphene. Theranostics. 2:283–294.
  • Shen J, Shi M, Li N, Yan B, Ma H, Hu Y, Ye M. 2010. Facile synthesis and application of Ag-chemically converted graphene nanocomposite. Nano Res. 3:339–349.
  • Sherlock SP, Tabakman SM, Xie L, Dai H. 2011. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano. 5:1505–1512.
  • Shi X, Chang H, Chen S, Lai C, Khademhosseini A, Wu H. 2012. Regulating cellular behavior on few‐layer reduced graphene oxide films with well‐controlled reduction states. Adv Funct Mater. 22:751–759.
  • Shi Y, Fang W, Zhang K, Zhang W, Li LJ. 2009. Photoelectrical response in single‐layer graphene transistors. Small. 5:2005–2011.
  • Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Grácio JJ, Dash D. 2012. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano. 6:2731–2740.
  • Siriviriyanun A, Imae T, Calderó G, Solans C. 2014. Phototherapeutic functionality of biocompatible graphene oxide/dendrimer hybrids. Colloids Surf B: Biointerfaces. 121:469–473.
  • Siriviriyanun A, Popova M, Imae T, Kiew LV, Looi CY, Wong WF, Lee HB, Chung LY. 2015. Preparation of graphene oxide/dendrimer hybrid carriers for delivery of doxorubicin. Chem Eng J. 281:771–781.
  • Stankovich S, Dikin DA, Dommett GH, Kohlhaas KM, Zimney EJ, Stach EA, Piner RD, Nguyen ST, Ruoff RS. 2006. Graphene-based composite materials. Nature. 442:282.
  • Sun X, Liu Z, Welsher K, Robinson JT, Goodwin A, Zaric S, Dai H. 2008. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1:203–212.
  • Szűts A, Szabó-Révész P. 2012. Sucrose esters as natural surfactants in drug delivery systems—A mini-review. Int J Pharm. 433:1–9.
  • Tang L, Wang Y, Li Y, Feng H, Lu J, Li J. 2009. Preparation, structure, and electrochemical properties of reduced graphene sheet films. Adv Funct Mater. 19:2782–2789.
  • Tian B, Wang C, Zhang S, Feng L, Liu Z. 2011. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano. 5:7000–7009.
  • Titov AV, Král P, Pearson R. 2010. Sandwiched graphene-membrane superstructures. ACS Nano. 4:229–234.
  • Tripathi SK, Goyal R, Gupta KC, Kumar P. 2013. Functionalized graphene oxide mediated nucleic acid delivery. Carbon. 51:224–235.
  • Vashist SK, Zheng D, Pastorin G, Al-Rubeaan K, Luong JH, Sheu F-S. 2011. Delivery of drugs and biomolecules using carbon nanotubes. Carbon. 49:4077–4097.
  • Veiseh O, Gunn JW, Zhang M. 2010. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 62:284–304.
  • Vinothini K, Rajan M. 2017. Investigation on the use of graphene as a unique drug delivery platform for dissimilar anticancer drugs. Progr Biosci Bioeng. 1:11–17.
  • Wagner V, Dullaart A, Bock A-K, Zweck A. 2006. The emerging nanomedicine landscape. Nat Biotechnol. 24:1211–1217.
  • Wang C, Li D, Too CO, Wallace GG. 2009. Electrochemical properties of graphene paper electrodes used in lithium batteries. Chem Mater. 21:2604–2606.
  • Wang C, Li J, Amatore C, Chen Y, Jiang H, Wang XM. 2011. Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer cells. Angew Chem Int Ed. 50:11644–11648.
  • Wang K, Ruan J, Song H, Zhang J, Wo Y, Guo S, Cui D. 2011. Biocompatibility of graphene oxide. Nanoscale Res Lett. 6:8.
  • Wang Y, Lee WC, Manga KK, Ang PK, Lu J, Liu YP, Lim CT, Loh KP. 2012. Fluorinated Graphene for Promoting neuro-induction of stem cells . Adv Mater Weinheim. 24:4285–4290.
  • Wang Y, Li Z, Hu D, Lin C-T, Li J, Lin Y. 2010. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J Am Chem Soc. 132:9274–9276.
  • Wang Y, Shao Y, Matson DW, Li J, Lin Y. 2010. Nitrogen-doped graphene and its application in electrochemical biosensing. ACS Nano. 4:1790–1798.
  • Wang Y, Shi Z, Huang Y, Ma Y, Wang C, Chen M, Chen Y. 2009. Supercapacitor devices based on graphene materials. J Phys Chem C. 113:13103–13107.
  • Wang Z, Zhou C, Xia J, Via B, Xia Y, Zhang F, Li Y, Xia L. 2013. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier. Colloids Surf B: Biointerfaces. 106:60–65.
  • Wate PS, Banerjee SS, Jalota-Badhwar A, Mascarenhas RR, Zope KR, Khandare J, Misra RDK. 2012. Cellular imaging using biocompatible dendrimer-functionalized graphene oxide-based fluorescent probe anchored with magnetic nanoparticles. Nanotechnology. 23:415101.
  • Wei G, Yan M, Dong R, Wang D, Zhou X, Chen J, Hao J. 2012. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug‐delivery system. Chem Eur J. 18:14708–14716.
  • Wen H, Dong C, Dong H, Shen A, Xia W, Cai X, Song Y, Li X, Li Y, Shi D. 2012. Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. Small. 8:760–769.
  • Wojtoniszak M, Chen X, Kalenczuk RJ, Wajda A, Łapczuk J, Kurzewski M, Drozdzik M, Chu PK, Borowiak-Palen E. 2012. Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide. Colloids Surf B: Biointerfaces. 89:79–85.
  • Wu J, Wang Y-s, Yang X-y, Liu Y-y, Yang J-r, Yang R, Zhang N. 2012. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology. 23:355101.
  • Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y. 2014. Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells. Int J Nanomed. 9:1413.
  • Xu X, Wang J, Wang Y, Zhao L, Li Y, Liu C. 2018. Formation of graphene oxide-hybridized nanogels for combinative anticancer therapy. Nanomedicine. 14:2387–2395.
  • Yan L, Zheng YB, Zhao F, Li S, Gao X, Xu B, Weiss PS, Zhao Y. 2012. Chemistry and physics of a single atomic layer: strategies and challenges for functionalization of graphene and graphene-based materials. Chem Soc Rev. 41:97–114.
  • Yang K, Feng L, Shi X, Liu Z. 2013. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 42:530–547.
  • Yang K, Gong H, Shi X, Wan J, Zhang Y, Liu Z. 2013. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials. 34:2787–2795.
  • Yang K, Li Y, Tan X, Peng R, Liu Z. 2013. Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small. 9:1492–1503.
  • Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. 2012. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials. 33:2206–2214.
  • Yang K, Wan J, Zhang S, Zhang Y, Lee S-T, Liu Z. 2011. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano. 5:516–522.
  • Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. 2010. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10:3318–3323.
  • Yang X, Chen Y, Yuan R, Chen G, Blanco E, Gao J, Shuai X. 2008. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer. 49:3477–3485.
  • Yang X, Wang Y, Huang X, Ma Y, Huang Y, Yang R, Duan H, Chen Y. 2011. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem. 21:3448–3454.
  • Yang X, Zhang X, Liu Z, Ma Y, Huang Y, Chen Y. 2008. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C. 112:17554–17558.
  • Yang X, Zhang X, Ma Y, Huang Y, Wang Y, Chen Y. 2009. Superparamagnetic graphene oxide–Fe3O4 nanoparticles hybrid for controlled targeted drug carriers. J Mater Chem. 19:2710–2714.
  • Yang Y, Zhang YM, Chen Y, Zhao D, Chen JT, Liu Y. 2012. Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery. Chem Eur J. 18:4208–4215.
  • Yang Z, Wang H, Zhao J, Peng Y, Wang J, Guinn B, Huang L. 2007. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther. 14:599.
  • Yoon HJ, Kim TH, Zhang Z, Azizi E, Pham TM, Paoletti C, Lin J, Ramnath N, Wicha MS, Hayes DF, et al. 2013. Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat Nanotech. 8:735.
  • Yuan J, Gao H, Sui J, Duan H, Chen WN, Ching CB. 2012. Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol Sci. 126:149–161.
  • Yun JM, Kim KN, Kim JY, Shin DO, Lee WJ, Lee SH, Lieberman M, Kim SO. 2012. DNA origami nanopatterning on chemically modified graphene. Angew Chem. 124:936–939.
  • Zhang F, Zheng B, Zhang J, Huang X, Liu H, Guo S, Zhang J. 2010. Horseradish peroxidase immobilized on graphene oxide: physical properties and applications in phenolic compound removal. J Phys Chem C. 114:8469–8473.
  • Zhang J, Zhang F, Yang H, Huang X, Liu H, Zhang J, Guo S. 2010. Graphene oxide as a matrix for enzyme immobilization. Langmuir. 26:6083–6085.
  • Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 83:761–769.
  • Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z. 2011. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI‐grafted graphene oxide. Small. 7:460–464.
  • Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. 2010. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 6:537–544.
  • Zhang S, Yang K, Feng L, Liu Z. 2011. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon. 49:4040–4049.
  • Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. 2011. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 32:8555–8561.
  • Zhang X, Yin J, Peng C, Hu W, Zhu Z, Li W, Fan C, Huang Q. 2011. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 49:986–995.
  • Zhang Y, Ali SF, Dervishi E, Xu Y, Li Z, Casciano D, Biris AS. 2010. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 4:3181–3186.
  • Zhao X, Liu P. 2014. Biocompatible graphene oxide as a folate receptor-targeting drug delivery system for the controlled release of anti-cancer drugs. Rsc Adv. 4:24232–24239.
  • Zhao X, Yang L, Li X, Jia X, Liu L, Zeng J, Guo J, Liu P. 2015. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem. 26:128–136.
  • Zhou T, Zhang B, Wei P, Du Y, Zhou H, Yu M, Yan L, Zhang W, Nie G, Chen C, et al. 2014. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials. 35:9833–9843.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.